BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

BrainStorm Cell Therapeutics Inc. 



Tel Aviv      Israel
Phone: n/a Fax:


SEARCH JOBS

View Clinical Trials from BioPharm Insight



Industry
Biotechnology






 Company News
BrainStorm Cell Therapeutics Inc. Says Stem Cell Drug Benefits ALS Patients in Mid-Stage Trial 4/21/2015 5:57:53 AM
BrainStorm Cell Therapeutics Inc. To Present Positive Nurown Phase 2a Clinical Data At American Academy of Neurology Annual Meeting 4/14/2015 9:40:22 AM
BrainStorm Cell Therapeutics Inc. Announces Financial Results For 2014 And Provides Business Update 3/26/2015 11:31:09 AM
BrainStorm Cell Therapeutics Inc. To Report Fourth Quarter And Full Year 2014 Financial Results On Thursday, March 26 3/20/2015 7:51:04 AM
BrainStorm Cell Therapeutics Inc. To Present At 3rd Annual Regen Med Investor Day On March 25 In New York 3/18/2015 9:41:52 AM
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015 8:54:14 AM
BrainStorm Cell Therapeutics Inc. CEO To Present At The 17th Annual Biotechnology Industry Organization (BIO) CEO & Investor Conference 2/4/2015 11:14:18 AM
BrainStorm Cell Therapeutics Inc. Announces Positive DSMB Recommendation In Ongoing Phase 2 Trial With NurOwn™ In ALS 2/3/2015 7:22:40 AM
BrainStorm Cell Therapeutics Inc. Announces Exceptional Preclinical Results Of Nurown™ In Mouse Autism Model 1/26/2015 10:04:50 AM
BrainStorm Cell Therapeutics Inc. Enters Into Warrant Exercise Agreement For Approximately $13 Million In Proceeds 1/8/2015 8:34:38 AM
12345678910...